Nicardipine Hydrochloride (Page 5 of 5)
Hypertension
The dose of nicardipine hydrochloride capsules should be individually adjusted according to the blood pressure response beginning with 20 mg three times daily. The effective doses in clinical trials have ranged from 20 mg to 40 mg three times daily. The maximum blood pressure lowering effect occurs approximately 1 to 2 hours after dosing. To assess the adequacy of blood pressure response, the blood pressure should be measured at trough (8 hours after dosing). Because of the prominent peak effects of nicardipine, blood pressure should be measured 1 to 2 hours after dosing, particularly during initiation of therapy (see PRECAUTIONS: Blood Pressure, INDICATIONS AND USAGE and CLINICAL PHARMACOLOGY: Effects in Hypertension). At least 3 days should be allowed before increasing the nicardipine hydrochloride capsules dose to ensure achievement of steady-state plasma drug concentrations.
Concomitant Use With Other Antihypertensive Agents
- 1.
- Diuretics: Nicardipine hydrochloride capsules may be safely coadministered with thiazide diuretics.
- 2.
- Beta-blockers: Nicardipine hydrochloride capsules may be safely coadministered with beta-blockers (see Drug Interactions).
Special Patient Populations
Renal Insufficiency
Although there is no evidence that nicardipine hydrochloride capsules impair renal function, careful dose titration beginning with 20 mg tid is advised (see PRECAUTIONS).
Hepatic Insufficiency
Nicardipine hydrochloride capsules should be administered cautiously in patients with severely impaired hepatic function. A suggested starting dose of 20 mg twice a day is advised with individual titration based on clinical findings maintaining the twice a day schedule (see PRECAUTIONS).
Congestive Heart Failure
Caution is advised when titrating nicardipine hydrochloride capsules dosage in patients with congestive heart failure (see WARNINGS).
HOW SUPPLIED
Nicardipine Hydrochloride Capsules 20 mg are available as hard gelatin capsules with an opaque light green cap and opaque light green body imprinted ‘ANI 205’ in black ink. They are supplied in bottles of 90 (NDC 62559-205-90).
Nicardipine Hydrochloride Capsules 30 mg are available as hard gelatin capsules with an opaque green cap and opaque light green body imprinted ‘ANI 206’ in black ink. They are supplied in bottles of 90 (NDC 62559-206-90).
Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature] and dispense in light-resistant containers.
All brand names listed are the registered trademarks of their respective owners and are not trademarks of ANI Pharmaceuticals, Inc.
Distributed by:
ANI Pharmaceuticals, Inc.
Baudette, MN 56623
10623 Rev 12/22
PACKAGE/LABEL PRINCIPAL DISPLAY PANEL
niCARdipine Hydrochloride Capsules, 20 mg
NDC 62559-205 -90
Rx only
90 Capsules
PACKAGE/LABEL PRINCIPAL DISPLAY PANEL
niCARdipine Hydrochloride Capsules, 30 mg
NDC 62559-206 -90
Rx only
90 Capsules
NICARDIPINE HYDROCHLORIDE nicardipine hydrochloride capsule | ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
|
NICARDIPINE HYDROCHLORIDE nicardipine hydrochloride capsule | ||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||
|
Labeler — ANI Pharmaceuticals, Inc. (145588013) |
Revised: 04/2023 ANI Pharmaceuticals, Inc.
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.
https://medlibrary.org/lib/rx/meds/nicardipine-hydrochloride-18/page/5/